Human artificial chromosomes for Duchenne muscular dystrophy and beyond: challenges and hopes
Abstract
Safe and efficacious vectors able to carry large or several transgenes are of key importance for gene therapy. Human artificial chromosomes can fulfil this essential requirement; moreover, they do not integrate into the host genome. However, drawbacks such as the low efficiency of chromosome transfer and their relatively complex engineering still limit their widespread use. In this article, I summarise the key steps that brought human artificial chromosomes into preclinical research for Duchenne muscular dystrophy, an X-linked, monogenic disorder. I will also review possible future pre-clinical and clinical perspectives for this technology.
Full text links
Publisher website (DOI) 10.1007/s10577-014-9460-6
Europe PubMed Central 25596829
Pubmed 25596829
Keywords
Type of publication